Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00057473
Status:
COMPLETED
Last Update Posted:
2011-04-14
First Post:
2003-04-02
Brief Title:
A Phase II Study of Carboplatin Plus Irinotecan Versus Irinotecan in Children With Refractory Solid Tumors
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Neoplasms |
Keywords:
| Name | View |
|---|---|
| unspecified childhood solid tumor protocol specific | View |